nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—BCHE—diaphragm—ovarian cancer	0.276	0.289	CbGeAlD
Dipivefrin—ADRA2C—myometrium—ovarian cancer	0.036	0.0376	CbGeAlD
Dipivefrin—BCHE—myometrium—ovarian cancer	0.0336	0.0351	CbGeAlD
Dipivefrin—ACHE—testis—ovarian cancer	0.0321	0.0336	CbGeAlD
Dipivefrin—ADRA1A—epithelium—ovarian cancer	0.0296	0.031	CbGeAlD
Dipivefrin—ADRA2A—myometrium—ovarian cancer	0.0287	0.03	CbGeAlD
Dipivefrin—ADRA2C—uterine cervix—ovarian cancer	0.028	0.0293	CbGeAlD
Dipivefrin—ADRA2C—decidua—ovarian cancer	0.0267	0.0279	CbGeAlD
Dipivefrin—BCHE—uterine cervix—ovarian cancer	0.0261	0.0273	CbGeAlD
Dipivefrin—ADRA2C—endometrium—ovarian cancer	0.0253	0.0265	CbGeAlD
Dipivefrin—BCHE—endometrium—ovarian cancer	0.0236	0.0247	CbGeAlD
Dipivefrin—ADRA2C—uterus—ovarian cancer	0.0233	0.0244	CbGeAlD
Dipivefrin—ACHE—lymph node—ovarian cancer	0.0233	0.0244	CbGeAlD
Dipivefrin—ADRA2A—uterine cervix—ovarian cancer	0.0223	0.0234	CbGeAlD
Dipivefrin—BCHE—uterus—ovarian cancer	0.0218	0.0228	CbGeAlD
Dipivefrin—ADRA2A—decidua—ovarian cancer	0.0213	0.0223	CbGeAlD
Dipivefrin—ADRA2A—endometrium—ovarian cancer	0.0202	0.0211	CbGeAlD
Dipivefrin—BCHE—female reproductive system—ovarian cancer	0.0196	0.0205	CbGeAlD
Dipivefrin—ADRA2C—female gonad—ovarian cancer	0.0191	0.02	CbGeAlD
Dipivefrin—ADRA2C—vagina—ovarian cancer	0.019	0.0198	CbGeAlD
Dipivefrin—ADRA2A—gonad—ovarian cancer	0.0187	0.0196	CbGeAlD
Dipivefrin—ADRA2A—uterus—ovarian cancer	0.0186	0.0195	CbGeAlD
Dipivefrin—BCHE—bone marrow—ovarian cancer	0.0185	0.0193	CbGeAlD
Dipivefrin—BCHE—vagina—ovarian cancer	0.0177	0.0185	CbGeAlD
Dipivefrin—ADRA2C—testis—ovarian cancer	0.0169	0.0177	CbGeAlD
Dipivefrin—ADRA2A—female reproductive system—ovarian cancer	0.0167	0.0175	CbGeAlD
Dipivefrin—BCHE—testis—ovarian cancer	0.0158	0.0165	CbGeAlD
Dipivefrin—ADRA2A—female gonad—ovarian cancer	0.0152	0.0159	CbGeAlD
Dipivefrin—ADRA2A—vagina—ovarian cancer	0.0151	0.0158	CbGeAlD
Dipivefrin—ADRA2A—testis—ovarian cancer	0.0135	0.0141	CbGeAlD
Dipivefrin—ADRA2C—lymph node—ovarian cancer	0.0123	0.0128	CbGeAlD
Dipivefrin—BCHE—lymph node—ovarian cancer	0.0114	0.012	CbGeAlD
Dipivefrin—ADRA2A—lymph node—ovarian cancer	0.00979	0.0102	CbGeAlD
Dipivefrin—ADRA2A—Signaling Pathways—PPP2R1A—ovarian cancer	1.95e-05	0.000443	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3CD—ovarian cancer	1.94e-05	0.000442	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PIK3CD—ovarian cancer	1.94e-05	0.000441	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—AKT1—ovarian cancer	1.94e-05	0.00044	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—CXCL8—ovarian cancer	1.93e-05	0.000438	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CG—ovarian cancer	1.92e-05	0.000437	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL2—ovarian cancer	1.91e-05	0.000435	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TERT—ovarian cancer	1.91e-05	0.000433	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PIK3CB—ovarian cancer	1.9e-05	0.000432	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CAV1—ovarian cancer	1.89e-05	0.000429	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CAV1—ovarian cancer	1.86e-05	0.000424	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	1.86e-05	0.000424	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—IL2—ovarian cancer	1.84e-05	0.000419	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PIK3CB—ovarian cancer	1.82e-05	0.000414	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ESR1—ovarian cancer	1.82e-05	0.000413	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—AKT1—ovarian cancer	1.81e-05	0.000411	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—PIK3CA—ovarian cancer	1.8e-05	0.000409	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ESR1—ovarian cancer	1.8e-05	0.000408	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—CXCL8—ovarian cancer	1.79e-05	0.000407	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6ST—ovarian cancer	1.79e-05	0.000407	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6ST—ovarian cancer	1.77e-05	0.000402	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CAV1—ovarian cancer	1.76e-05	0.000401	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—CXCL8—ovarian cancer	1.75e-05	0.000398	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—TP53—ovarian cancer	1.74e-05	0.000395	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—APC—ovarian cancer	1.72e-05	0.000391	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CG—ovarian cancer	1.72e-05	0.000391	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—NRAS—ovarian cancer	1.72e-05	0.000391	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—CAV1—ovarian cancer	1.71e-05	0.000389	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—IL2—ovarian cancer	1.71e-05	0.000389	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ESR1—ovarian cancer	1.7e-05	0.000386	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—APC—ovarian cancer	1.7e-05	0.000386	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CG—ovarian cancer	1.7e-05	0.000386	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—NRAS—ovarian cancer	1.7e-05	0.000386	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3CB—ovarian cancer	1.69e-05	0.000385	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PIK3CB—ovarian cancer	1.69e-05	0.000385	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CD—ovarian cancer	1.69e-05	0.000384	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL2—ovarian cancer	1.67e-05	0.00038	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6ST—ovarian cancer	1.67e-05	0.00038	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TERT—ovarian cancer	1.67e-05	0.000379	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—HRAS—ovarian cancer	1.66e-05	0.000378	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK3—ovarian cancer	1.65e-05	0.000374	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PTEN—ovarian cancer	1.64e-05	0.000373	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—CXCL8—ovarian cancer	1.63e-05	0.00037	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK3—ovarian cancer	1.63e-05	0.00037	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CG—ovarian cancer	1.61e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—APC—ovarian cancer	1.61e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—NRAS—ovarian cancer	1.61e-05	0.000365	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—MAPK1—ovarian cancer	1.57e-05	0.000356	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—EGFR—ovarian cancer	1.57e-05	0.000356	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CG—ovarian cancer	1.56e-05	0.000355	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL2—ovarian cancer	1.55e-05	0.000353	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TERT—ovarian cancer	1.55e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—MAPK1—ovarian cancer	1.55e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—EGFR—ovarian cancer	1.55e-05	0.000352	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CAV1—ovarian cancer	1.54e-05	0.00035	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK3—ovarian cancer	1.54e-05	0.00035	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CD—ovarian cancer	1.51e-05	0.000344	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—PIK3CA—ovarian cancer	1.5e-05	0.00034	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CD—ovarian cancer	1.49e-05	0.000339	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ESR1—ovarian cancer	1.49e-05	0.000338	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—KRAS—ovarian cancer	1.48e-05	0.000336	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—PIK3CA—ovarian cancer	1.48e-05	0.000336	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CB—ovarian cancer	1.47e-05	0.000335	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—AKT1—ovarian cancer	1.47e-05	0.000334	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PTEN—ovarian cancer	1.46e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—MAPK1—ovarian cancer	1.46e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—EGFR—ovarian cancer	1.46e-05	0.000333	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6ST—ovarian cancer	1.46e-05	0.000332	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—KRAS—ovarian cancer	1.46e-05	0.000332	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CAV1—ovarian cancer	1.43e-05	0.000326	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CD—ovarian cancer	1.41e-05	0.000321	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—APC—ovarian cancer	1.4e-05	0.000319	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CG—ovarian cancer	1.4e-05	0.000319	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—NRAS—ovarian cancer	1.4e-05	0.000319	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—PIK3CA—ovarian cancer	1.4e-05	0.000318	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—KRAS—ovarian cancer	1.38e-05	0.000314	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ESR1—ovarian cancer	1.38e-05	0.000314	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CD—ovarian cancer	1.37e-05	0.000312	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—PIK3CA—ovarian cancer	1.36e-05	0.000309	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6ST—ovarian cancer	1.36e-05	0.000309	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK3—ovarian cancer	1.35e-05	0.000306	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—PIK3CA—ovarian cancer	1.34e-05	0.000305	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—ERBB2—ovarian cancer	1.34e-05	0.000303	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—ERBB2—ovarian cancer	1.32e-05	0.0003	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CB—ovarian cancer	1.32e-05	0.000299	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MTOR—ovarian cancer	1.32e-05	0.000299	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CG—ovarian cancer	1.31e-05	0.000297	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—APC—ovarian cancer	1.31e-05	0.000297	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—NRAS—ovarian cancer	1.3e-05	0.000297	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MTOR—ovarian cancer	1.3e-05	0.000296	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CB—ovarian cancer	1.3e-05	0.000296	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—MAPK1—ovarian cancer	1.28e-05	0.000291	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—EGFR—ovarian cancer	1.28e-05	0.000291	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PTEN—ovarian cancer	1.27e-05	0.000289	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—PIK3CA—ovarian cancer	1.27e-05	0.000289	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CXCL8—ovarian cancer	1.27e-05	0.000288	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—HRAS—ovarian cancer	1.26e-05	0.000286	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CXCL8—ovarian cancer	1.25e-05	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK3—ovarian cancer	1.25e-05	0.000284	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—ERBB2—ovarian cancer	1.25e-05	0.000283	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—HRAS—ovarian cancer	1.24e-05	0.000282	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CDKN1B—ovarian cancer	1.24e-05	0.000281	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CD—ovarian cancer	1.23e-05	0.000281	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MTOR—ovarian cancer	1.23e-05	0.00028	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CB—ovarian cancer	1.23e-05	0.00028	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AKT1—ovarian cancer	1.22e-05	0.000278	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—PIK3CA—ovarian cancer	1.22e-05	0.000278	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CDKN1B—ovarian cancer	1.22e-05	0.000277	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CASP3—ovarian cancer	1.21e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL2—ovarian cancer	1.21e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—KRAS—ovarian cancer	1.21e-05	0.000275	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AKT1—ovarian cancer	1.21e-05	0.000274	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—IL6—ovarian cancer	1.2e-05	0.000274	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CASP3—ovarian cancer	1.2e-05	0.000272	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CB—ovarian cancer	1.2e-05	0.000272	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL2—ovarian cancer	1.19e-05	0.000272	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—MAPK1—ovarian cancer	1.19e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—IL6—ovarian cancer	1.19e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—EGFR—ovarian cancer	1.19e-05	0.00027	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CXCL8—ovarian cancer	1.18e-05	0.000269	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CCND1—ovarian cancer	1.18e-05	0.000268	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—HRAS—ovarian cancer	1.18e-05	0.000267	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CTNNB1—ovarian cancer	1.17e-05	0.000266	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CCND1—ovarian cancer	1.16e-05	0.000265	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PIK3CA—ovarian cancer	1.16e-05	0.000263	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CDKN1B—ovarian cancer	1.16e-05	0.000263	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CTNNB1—ovarian cancer	1.15e-05	0.000262	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CD—ovarian cancer	1.15e-05	0.000261	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MMP9—ovarian cancer	1.15e-05	0.00026	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AKT1—ovarian cancer	1.14e-05	0.00026	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PTEN—ovarian cancer	1.14e-05	0.000259	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	1.14e-05	0.000258	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CASP3—ovarian cancer	1.13e-05	0.000257	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MMP9—ovarian cancer	1.13e-05	0.000257	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL2—ovarian cancer	1.13e-05	0.000257	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—IL6—ovarian cancer	1.12e-05	0.000256	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PTEN—ovarian cancer	1.12e-05	0.000255	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—KRAS—ovarian cancer	1.12e-05	0.000255	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AKT1—ovarian cancer	1.11e-05	0.000252	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	1.11e-05	0.000252	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CCND1—ovarian cancer	1.1e-05	0.00025	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AKT1—ovarian cancer	1.1e-05	0.000249	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CTNNB1—ovarian cancer	1.09e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	1.09e-05	0.000248	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	1.08e-05	0.000245	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	1.08e-05	0.000245	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MMP9—ovarian cancer	1.07e-05	0.000243	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PTEN—ovarian cancer	1.06e-05	0.000242	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AKT1—ovarian cancer	1.04e-05	0.000236	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	1.03e-05	0.000235	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PTEN—ovarian cancer	1.03e-05	0.000235	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3CA—ovarian cancer	1.03e-05	0.000235	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	1.03e-05	0.000234	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VEGFA—ovarian cancer	1.03e-05	0.000234	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	1.03e-05	0.000233	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—STAT3—ovarian cancer	1.02e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—NRAS—ovarian cancer	1.02e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VEGFA—ovarian cancer	1.02e-05	0.000231	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	1.01e-05	0.00023	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	1.01e-05	0.00023	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—STAT3—ovarian cancer	1.01e-05	0.000228	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—NRAS—ovarian cancer	1e-05	0.000228	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	1e-05	0.000227	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	1e-05	0.000227	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	9.99e-06	0.000227	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	9.9e-06	0.000225	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL2—ovarian cancer	9.88e-06	0.000225	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	9.83e-06	0.000223	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK3—ovarian cancer	9.73e-06	0.000221	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	9.64e-06	0.000219	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	9.61e-06	0.000218	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	9.61e-06	0.000218	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK3—ovarian cancer	9.61e-06	0.000218	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	9.55e-06	0.000217	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	9.54e-06	0.000217	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	9.51e-06	0.000216	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	9.49e-06	0.000216	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MYC—ovarian cancer	9.46e-06	0.000215	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—AKT1—ovarian cancer	9.46e-06	0.000215	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	9.38e-06	0.000213	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	9.35e-06	0.000213	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MYC—ovarian cancer	9.34e-06	0.000212	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	9.3e-06	0.000211	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	9.28e-06	0.000211	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	9.26e-06	0.00021	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	9.26e-06	0.00021	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	9.2e-06	0.000209	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL2—ovarian cancer	9.18e-06	0.000209	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—MAPK1—ovarian cancer	9.14e-06	0.000208	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—EGFR—ovarian cancer	9.14e-06	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	9.14e-06	0.000208	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	9.09e-06	0.000207	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	9.07e-06	0.000206	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3CA—ovarian cancer	8.98e-06	0.000204	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	8.95e-06	0.000203	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	8.87e-06	0.000201	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MYC—ovarian cancer	8.84e-06	0.000201	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	8.75e-06	0.000199	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	8.69e-06	0.000198	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	8.65e-06	0.000197	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	8.65e-06	0.000196	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	8.64e-06	0.000196	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—KRAS—ovarian cancer	8.63e-06	0.000196	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—AKT1—ovarian cancer	8.44e-06	0.000192	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	8.43e-06	0.000192	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	8.4e-06	0.000191	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	8.32e-06	0.000189	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	8.3e-06	0.000189	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	8.17e-06	0.000186	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	8.03e-06	0.000183	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	7.95e-06	0.000181	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PIK3CA—ovarian cancer	7.93e-06	0.00018	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	7.8e-06	0.000177	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TP53—ovarian cancer	7.77e-06	0.000177	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MYC—ovarian cancer	7.73e-06	0.000176	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	7.73e-06	0.000176	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	7.71e-06	0.000175	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TP53—ovarian cancer	7.67e-06	0.000174	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	7.56e-06	0.000172	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	7.56e-06	0.000172	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	7.5e-06	0.000171	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	7.43e-06	0.000169	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	7.38e-06	0.000168	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—HRAS—ovarian cancer	7.34e-06	0.000167	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—AKT1—ovarian cancer	7.33e-06	0.000167	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3CA—ovarian cancer	7.29e-06	0.000166	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TP53—ovarian cancer	7.26e-06	0.000165	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MYC—ovarian cancer	7.18e-06	0.000163	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	7.14e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IL6—ovarian cancer	7.11e-06	0.000162	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	7.02e-06	0.00016	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IL6—ovarian cancer	7.02e-06	0.00016	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	7.02e-06	0.00016	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	6.94e-06	0.000158	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IL6—ovarian cancer	6.65e-06	0.000151	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	6.64e-06	0.000151	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	6.56e-06	0.000149	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	6.56e-06	0.000149	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AKT1—ovarian cancer	6.48e-06	0.000147	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TP53—ovarian cancer	6.35e-06	0.000144	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	6.13e-06	0.000139	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	6.1e-06	0.000139	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	6.07e-06	0.000138	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—AKT1—ovarian cancer	5.96e-06	0.000135	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TP53—ovarian cancer	5.9e-06	0.000134	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IL6—ovarian cancer	5.81e-06	0.000132	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	5.64e-06	0.000128	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IL6—ovarian cancer	5.4e-06	0.000123	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	5.36e-06	0.000122	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	4.98e-06	0.000113	CbGpPWpGaD
